Transcervical-subxiphoid-videothoracoscopic "maximal" Thymectomy--operative Technique and Early Results
Overview
Pulmonary Medicine
Affiliations
Background: The operative technique of a transcervical-subxiphoid-videothoracoscopic "maximal" thymectomy without sternotomy is described and the early results of the follow-up of patients operated on are analyzed.
Methods: One-hundred "maximal" transcervical-subxiphoid-videothoracoscopic thymectomies were performed for nonthymomatous myasthenia gravis during a recent 32-month period (from September 1, 2000 to May 8, 2003). Patient characteristics, complications, pathologic findings, and the results of follow-up were analyzed.
Results: The study group included 83 women and 17 men. The mean age was 29.8 years (range, 10-69 years). The mean preoperative duration of myasthenia was 2.73 years (range, 3 months to 17 years). The preoperative Osserman score was I-III, 27 patients were taking steroids preoperatively. Eleven operations were performed by two teams working simultaneously and 89 operations were performed by one surgeon including four combined thymectomy-thyroid operations in patients with myasthenia and thyroid nodules. The mean operative time for two-team approach thymectomies was 159.09 minutes (range, 140-170 minutes) and the mean operative time for the thymectomy performed by one surgeon was 199.41 minutes (range, 150-270 minutes) (p = 0.0004). There was a 15.0% (15 out of 100) postoperative morbidity and no mortality. Foci of ectopic thymic tissue were found in 71.0% of the patients and were most prevalent in the perithymic fat (37.0%) and in the aorta-pulmonary window (33.0%). The mean weight of the specimen was 78.4 g (range, 14.5-253.0 g). In 48 patients followed-up for 12 months, the improvement rate was 83.3%, the no improvement rate was 14.6%, and 1 patient died during the follow-up period. Complete remission rates were 18.8% and 32.0% after 1 and 2 years of follow-up, respectively.
Conclusions: We conclude that the "maximal" transcervical-subxiphoid-videothoracoscopic thymectomy is a safe operative technique, avoiding a sternotomy, performed partly in an open fashion with the extensiveness comparable with the transsternal extended and "maximal" thymectomies. The two-team approach helps to reduce the operative time. However, because of the limited time of follow-up it is too early for the final assessment of the long-term results of this method in the treatment of myasthenia gravis.
A proof-of-concept study: advantages of the subxiphoid over the lateral intercostal approach.
He G, Yao T, Zhao L, Geng H, Ji Q, Zuo K Interdiscip Cardiovasc Thorac Surg. 2024; 38(5).
PMID: 38632049 PMC: 11112048. DOI: 10.1093/icvts/ivae067.
Trujillo Reyes J, Martinez Tellez E, Belda Sanchis J, Planas Canovas G, Libreros Nino A, Guarino M Front Neurol. 2024; 15:1309173.
PMID: 38361645 PMC: 10867208. DOI: 10.3389/fneur.2024.1309173.
Wang J, Tong T, Zhang K, Guo H, Liu Y, Li J BMC Cancer. 2024; 24(1):92.
PMID: 38233754 PMC: 10795346. DOI: 10.1186/s12885-024-11832-7.
Modified subxiphoid thoracoscopic thymectomy for early-stage thymic tumor: case report.
Jiang J, Zhang Y, Ding J Mediastinum. 2023; 7:38.
PMID: 38090034 PMC: 10713240. DOI: 10.21037/med-21-23.
Menghesha H, Schroeter M, Nelke C, Ruck T, Schlachtenberger G, Welskop C Neurol Res Pract. 2023; 5(1):24.
PMID: 37316910 PMC: 10268481. DOI: 10.1186/s42466-023-00252-w.